NCT03143348View on ClinicalTrials.gov

Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

June 4, 2017

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Congenital Heart DefectCardiopulmonary BypassInflammatory ResponseLow Cardiac Output SyndromeInflammation
Interventions
PROCEDURE

Single blood draw

One blood draw of 0.5 ml volume prior to discharge

PROCEDURE

Multiple blood draws

Blood draw at 6 peri-operative time points.

PROCEDURE

Multiple blood draws

Blood draw at 7 peri-operative time points

Trial Locations (1)

73117

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT03143348 - Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter